| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.017 | 0.9 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |